Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Home

Header Top Menu

  • Careers
  • Investors
  • News
    • Press Release Archive
    • Press Statements
    • Podcasts
      • The Antigen Podcast Season 1
        • The Antigen Podcast Episode 1: Vaccines 101
        • The Antigen Podcast Episode 2: The History of Vaccines
        • The Antigen Podcast Episode 3: Global Perspectives, Barriers & Solutions
        • The Antigen Podcast Episode 4: Vaccine Hesitancy Part 1
        • The Antigen Podcast Episode 5: Vaccine Hesitancy Part 2
        • The Antigen Podcast Episode 6: Vaccine Politics, Policy & Advocacy
        • The Antigen Podcast Episode 7: Innovations in the Vaccine Landscape
        • The Antigen Podcast Episode 8: What's Next?
      • The Antigen Podcast Season 2
      • Get Science Podcast
      • Diverse Perspectives Podcast
      • menopause: unmuted
    • Contact Media Relations
    • Press Kits & Downloads
      • Company Press Kit
      • Breast Cancer: A Story Half Told Press Kit
      • Pfizer Oncology Press Kit
      • PSA Narrative
      • Rare Disease Gene Therapy Press Kit
      • TTR-Amyloidosis Press Kit
      • UC Narrative
  • Partners
    • Discovery to Pre-candidate
      • Focus Areas
        • Therapeutic Areas
          • Internal Medicine
          • Inflammation and Immunology
          • Oncology
          • Rare Disease
          • Vaccines
        • Therapeutic Modalities and Technology Platforms
          • Drug Safety
          • Gene Therapy
          • Target Sciences
          • Precision Medicine
          • Medicinal Sciences
            • Biologics Product & Process Development
            • Biotherapeutics Discovery
            • Medicine Design
            • Small Molecule Product & Process Development
        • Emerging Science
          • DNA Damage Response
          • Microsatellite Repeat Expansions
          • Tissue Resident Immunity
      • Partnering Models
    • Candidate Through Commercialization
      • Focus Areas
        • Internal Medicine
        • Inflammation and Immunology
        • Oncology
        • Rare Disease
        • Vaccines
        • Hospital
    • Pfizer CentreOne
    • Pfizer Ventures
      • Our portfolio

Healthcare Professionals

  • Healthcare Professionals

Connect with Us

  • Connect with Us
    • Email
    • FAQ
    • Privacy Policy (NEW)
    • YouTube
    • Twitter
    • Facebook
    • LinkedIn
    • Instagram
  • Your Health

    • Healthy Living
      • Brain & Nervous System
      • Cardiovascular Health
      • Cold & Flu
      • Digestive Health
      • Healthier Aging
      • Living Tobacco Free
      • Men’s Health
      • Mental Health
      • Nutrition & Fitness
      • Pediatric Health
      • Respiratory Health
      • Skin Health
      • Vaccines & Prevention
      • Women’s Health

    • Disease & Condition
      • Cancer
      • Cardiovascular Diseases & Conditions
      • Diabetes & Metabolic Disorders
      • Immune System Diseases & Conditions
      • Infections & Infectious Diseases
      • Neurological Diseases & Conditions
      • Menopause
      • Rare Disease
      • Vaccine-Related Conditions
      • Skin Diseases & Conditions

    • Coronavirus disease (COVID-19)

    • Managing your health
      • Caregiving
      • Evaluating Health Information
      • Tracking Your Health
      • Your Medicines
      • Health Literacy

    • Wellness
    Hot Topics

    Maintaining Emotional Well-Being During COVID-19

    Emotional Well-Being Tips for People Living with Chronic Inflammatory Conditions During COVID-19
  • Our Science

    • Driven to Discover the cure

    • Focus Areas
      • Internal Medicine
      • Inflammation & Immunology
      • Oncology
      • Rare Disease
      • Vaccines
      • Anti Infectives

    • Product Pipeline

    • Clinical Trials
      • Guide to Clinical Trials
      • Find a Trial
      • Expanded Access & Compassionate Use
      • Clinical Trials in Children
      • Partnering with Pfizer
      • Trial Data & Results
      • Research Integrity & Transparency

    • R&D Platforms
      • Biosimilars
      • Gene Therapy
      • Medicinal Sciences
      • Precision Medicine
      • Maternal Immunization

    • Collaboration
      • Partner with Pfizer

    • Research sites

    • Coronavirus disease (COVID-19) Scientific Resources
    HOT TOPICS

    COVID-19 Vaccine Candidates Facts

    Get the Facts on Our COVID-19 Vaccine Candidates

    MRNA VS. CONVENTIONAL VACCINES

    What Makes an RNA Vaccine Different From a Conventional Vaccine?
  • Our People

    • Meet The Experts
      • Scientists
      • Internal Medicine – Metabolic Disease
      • Inflammation & Immunology
      • Oncology
      • Rare Disease
      • Vaccines
      • Medical Professionals

    • The Journey

    • Leadership
      • Executives
      • Board Members
      • Company Fact Sheet

    • Diverse Perspectives
      • Diversity & Inclusion
      • Supplier Diversity
    HOT TOPICS

    A Day in the Life of a Scientist

    A Day in the Life of a Scientist (In the time of Coronavirus)

    Getting to Know CPO Dara Richardson-Heron, M.D.

    dr_richardson_300x170.jpg

    • Hot Topics
  • Our Purpose

    • Commitment to Global Health
      • Expanding Access
      • Strengthening Health Systems
      • Providing Disaster & Humanitarian Relief
      • Unleashing the Power of Our Colleagues
      • Highlighting Individual Voices

    • Protecting People and the Environment
      • Pfizer's Green Journey
      • Product Stewardship
      • EHS Governance
      • EHS Supply Chain
      • Key Performance Indicators
      • Health & Safety

    • Positions on Health Policies
      • Ready for Cures
      • How does Pfizer price medicines?
      • Value of Medicines
      • Policy Positions
      • Creating Cures Through Facility Investments

    • Transparency
      • Working with Health Care Professionals
      • Transparency in Grants
      • Code of Conduct
      • Corporate Compliance
      • Sales and Marketing Compliance

    • Independent Grants
      • Competitive Grants Program
      • Independent Medical Education
      • Investigator Sponsored Research
      • Quality Improvement

    • Contributions & Partnerships
      • Healthcare Charitable Contributions
      • Lobbying & Political Contributions
    HOT TOPICS

    Pfizer Women’s Resource Group

    Media Name: IWD_Pull_up_Banner_300x170.jpg

    • Hot Topics
  • Our Products

    • Product listing

    • How drugs are made
      • Branded vs. Generic
      • Biologics & Biosimilars
      • Commitment to Quality

    • Upjohn
      • About Upjohn
      • Portfolio of Brands
      • Manufacturing Plants
      • UpJohn Leadership

    • Distributors
      • Pfizer Distributors
      • Greenstone Distributors

    • Medicine Safety
      • Reporting Adverse Events
      • Making Good Treatment Choices
      • Partnering With Patients
      • Health Literacy
      • Medicine Safety Tips for Patients
      • Counterfeiting
      • Unused Medicines

    • Safety Data Sheets

    • Medical Information Contacts

    • Pfizer Global Supply
    HOT TOPICS

    Scaling Up to Supply a COVID-19 Vaccine, If Approved

    Scaling Up to Manufacture and Supply a COVID-19 Vaccine, If Approved

    Universal vs. Single Payer Healthcare

    Media Name: universal_healthcare300x170.jpg

    • Hot Topics
  • Careers

    • Working Here
      • Mission & Purpose
      • Culture
      • Diversity & Inclusion
      • Career Growth & Colleague Development
      • Compensation & Benefits
      • Ensuring Corporate Responsibility
    • Search Jobs
    • Student & Early Career
      • Postdoctoral Program
      • US Summer Student Worker Program
      • Opportunities for Veterans
    • Pfizer365.com
    • Our Hiring & Recruiting Process
      • Frequently Asked Questions
      • Tips for Interviewing at Pfizer
    • Connect With Us
  • Investors

    • Investors Overview
      • Why Invest / Our Story
      • Prospective Investors
      • Fact Sheet
    • Events & Presentations
    • Financials
      • Quarterly Reports
      • Annual Reports
      • SEC Filings
      • Interactive Data Filings
    • Investor News
    • Stock Information
      • Historical Price Lookup
      • Investment Calculator
      • Historical Stock Chart & Data
      • Dividend & Split History
      • Stock FAQs
    • Governance
      • Board Committees and Charters
      • The Pfizer Board Policies
      • Corporate Governance FAQs
      • Contact Our Directors
    • Shareholder Services
      • Stock FAQs
      • Advisory Information
      • Cost Basis Calculator
  • News

    • Contact Media Relations
    • Podcasts
    • Press Kits & Downloads
    • Press Release Archive
    • Press Statements
  • Partners
  • Footer links

    • Footer Aside Section1
      • CAREER-SEEKERS
      • INVESTORS
      • News & Media
      • Partners
    • Footer Aside Section 2
      • Healthcare Professionals
      • Business To Business
      • Change Region
      • Sitemap
    • Footer Aside Section3
      • Twitter
      • Facebook
      • Linkedin
      • Instagram
      • Youtube
    • Footer Aside Section4
      • Contact Us
      • Terms of Use
      • Privacy Policy

Age: Addressing a Blind Spot in Cancer Care

Age: Addressing a Blind Spot in Cancer Care
OUR PURPOSE/ Age: Addressing a Blind Spot in Cancer Care
June 23, 2020

In last decade, we have seen breakthrough progress in our ability to help prevent, diagnose, and treat cancer. But today, too many people living with cancer still face barriers to timely and equitable care. At Pfizer, we’re focused on removing those barriers for all people living with cancer – including those over the age of 65 – to address disparities in cancer care and improve health equity.

Age is the greatest risk factor for developing cancer, with approximately 54% of cancers occurring in people over the age of 65.1 Yet, research shows that due to medical, policy, and societal challenges, older people living with cancer may not be getting optimal care, putting them at a greater risk of dying from the disease.

Age must no longer be a blind spot in cancer care.

SOCIETY HAS AN AGE BIAS

Despite living vibrant, full, and more active lives, older people within our communities and our healthcare system have become unintentionally marginalized.2,3 Older people report frequently having their concerns dismissed by healthcare professionals. For example, in a 2015 study, people 65 and older reported poorer medical service and frequent dismissals of their concerns due to their age.4

And ageism in our healthcare system has serious consequences leading to worse care. In fact, a longitudinal analysis of data found that one in five older people self-reported experiencing “poorer service or treatment than other people from doctors or hospitals” at least once a year, with one in 17 experiencing it frequently.5 More tragically, the COVID-19 pandemic exposed how age impacts a person’s likelihood of receiving scarce medical resources.6

DIFFERENCES IN CARE BASED ON AGE

Studies show those over the age of 65 may not always be getting the best care. We see different treatment decisions by age across multiple cancer types including colon, prostate, breast, lung, and some blood cancers. For example, one study of older patients with stage III non-small cell lung cancer revealed that approximately 62.7% of patients aged 80 years and older received no cancer-directed care, which was associated with a lower overall survival compared to those receiving treatment.7 Another study reported that increasing age was found to be a contributing factor in the approximately 25% of adults with acute myeloid leukemia who did not receive chemotherapy.8

OLDER PEOPLE WITH CANCER FACE UNIQUE CHALLENGES, WHICH ARE EXACERBATED BY RACIAL, SOCIOECONOMIC AND GEOGRAPHIC BARRIERS

Aging and cancer care is complex. There are many factors contributing to why older people living with cancer experience worse outcomes, spanning across medical, societal, and policy arenas. These issues related to age are only further exacerbated by racial, socioeconomic, and geographic barriers to care. For older Black people, for example, the data show that they are more likely to die of cancer than older white people in the United States.9,10

First, healthcare professionals have limited clinical trial data and tools on which to base their recommendations for treatment. Despite comprising the majority of people living with cancer, only ~40% of enrollees in registration trials of new cancer therapies were over the age of 65, making it harder for healthcare professionals to make treatment decisions based on available research.11 Additionally, while comprehensive geriatric assessments exist to support better cancer care for those over 65, a survey found that only 17% of healthcare professionals routinely use them.12

Second, there are gaps in effective resources and support to guide older people in their care, which contribute to this systemic problem. A 2018 study found older adults living with cancer had high levels of unmet medical and informational support needs, ranging from how to recognize and address health issues to understanding physician recommendations.13

Third, unintended distortions in policy, such as zero ceilings on Medicare co-pays and limited coverage to address social determinants of health, including transit to and from appointments for patients, have created frustrating roadblocks to adequate care.

WORKING TOWARD CHANGE

We must address the issue of disparities in care for older people. That’s why we are working with the cancer, aging, caregiving, and underserved communities to tackle the barriers standing in the way of optimal care for these individuals. A sample of our partnerships and initiatives to create change include:

  • With the Association of Community Cancer Centers (ACCC), we are supporting a self-assessment tool for healthcare professionals to identify areas for improvement in the care of older populations
  • With the Academy of Oncology Nurse & Patient Navigators (AONN+), we are creating a Navigator Module to educate oncology nurse navigators and patient navigators on how to support the needs of older people living with cancer including a focus on people of color
  • With the American Cancer Society, we have awarded grants to help reduce disparities between whites and Blacks with breast and prostate cancers
  • With Patient Empowerment Network, we supported the creation of videos to help older people use technology to navigate their cancer journey
  • We launched a new section on This Is Living With Cancer called As We Age. Through this platform, we’re providing dedicated resources, education, and encouragement for older people with cancer and their caregivers

Pfizer is dedicated to the cause of equality for all ages in cancer care. We will continue to address the specific needs of older people living with cancer, working with healthcare professionals, policymakers, patient advocates, researchers, and caregivers to inform our efforts.

Cancer doesn’t discriminate, and neither should cancer care. We encourage you to seek out information and resources to support improved cancer care for those ages 65 years and older.


1National Cancer Institute (NCI): SEER Cancer Stat Facts: Cancer of Any Site
2Bureau of Labor Statistics (BLS): Current Population Survey, Employment Status 2019
3AARP: Giving Back: Attitudes and Behavior Across Lifespan
4 Makris: BMC Geriatr 2015)
5 Rogers: J Gen Intern Med 2015)
6Los Angeles Times, Newberry (May 1, 2020): The pandemic has amplified ageism. ‘It’s open season for discrimination’ against older adults
7 Cassidy: Cancer 2018)
8 Bhatt: Blood Adv 2018)
9 DeSantis: CA Cancer J Clin 2019)
10 Marron: J Am Geriatr Soc 2018)
11 Singh: 2017 ASCO Annual Meeting)
12 Plotkin: Oncol Issues 2019)

Age must no longer be a blind spot in cancer care.

Related Hot Topics
Ask an Expert: Professor Joe Schmitt Talks Tick-Borne Encephalitis
Ask an Expert: Professor Joe Schmitt Talks Tick-Borne Encephalitis
Health Disparities Among Asian Americans and Pacific Islanders
Health Disparities Among Asian Americans and Pacific Islanders
Scaling Up to Manufacture and Supply a COVID-19 Vaccine, If Approved
Scaling Up to Manufacture and Supply a COVID-19 Vaccine, If Approved
Get the Facts on Our COVID-19 Vaccine Candidates
Get the Facts on Our COVID-19 Vaccine Candidates
Thumbnail Impact of COVID-19
Understanding the Impact of COVID-19 and Tips for Those Living with a Chronic…
Answering your COVID-19 questions
Answering Your COVID-19 Questions
VizagWomen_300x170.jpg
Working Together to Empower Women
rdd_300x170.jpg
Reframing Rare Diseases
Tags
Caregiving
Diversity and Inclusion
Health Info
Healthcare
Patient Impact
Show
Hide

Footer menu

  • Your Health
    • Healthy Living
    • Disease Conditions
    • Manage Your Health
  • Our Science
    • Therapeutic Areas
    • Product Pipeline
    • Clinical Trials
    • R&D Platforms
    • Collaboration
    • Research SItes
  • Our People
    • Meet the Experts
    • The Journey
    • Leadership
    • Diverse Perspectives
  • Our Purpose
    • Commitment To Global Health
    • Positions on Health Policies
    • Transparency
    • Contributions & Partnerships
  • Our Products
    • Product Listing
    • How Drugs are Made
    • Distributors
    • Global Product Information Contacts

Footer aside

  • Footer Aside Section1
    • CAREER-SEEKERS
    • INVESTORS
    • News & Media
    • Partners
  • Footer Aside Section 2
    • Healthcare Professionals
    • Business To Business
    • Change Region
    • Sitemap
  • Footer Aside Section3
    • Twitter
    • Facebook
    • Linkedin
    • Instagram
    • Youtube
  • Footer Aside Section4
    • Contact Us
    • Terms of Use
    • Privacy Policy
Pfizer Logo Footer

Copyright © 2002-2020 Pfizer Inc. All rights reserved. This information—including product information—is intended only for residents of the United States.
The products discussed herein may have different labeling in different countries.